Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Webull is a leading global digital investment platform that provides a comprehensive suite of financial products and services to self-directed investors. Headquartered in St. Petersburg, Florida, the company offers commission-free trading for stocks, ETFs, options, and fractional shares through its mobile-first application and desktop platform. Webull distinguishes itself with advanced charting tools, real-time market data, and a community-driven experience designed for both novice and experienced traders. Following its public listing on Nasdaq in 2025 via a business combination with SK Growth Opportunities Corp, Webull continues to expand its global footprint across Asia Pacific, Europe, and Latin America. The platform also features a "Corporate Connect" service that enables public companies, including those in the biotechnology and healthcare sectors, to engage directly with retail shareholders through digital communication channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Webull.